Filter Results:
(2,526)
Show Results For
- All HBS Web
(5,239)
- People (16)
- News (1,913)
- Research (2,526)
- Events (3)
- Multimedia (216)
- Faculty Publications (1,924)
Show Results For
- All HBS Web
(5,239)
- People (16)
- News (1,913)
- Research (2,526)
- Events (3)
- Multimedia (216)
- Faculty Publications (1,924)
Sort by
- 23 Jan 2018
- First Look
First Look at New Research and Ideas, January 23, 2018
consequence of actual leverage than it is of risk premiums. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=53733 2017 India as a Pioneer of Innovation The Private Provision of Missing Public Goods: Evidence from Narayana View Details
Keywords: Sean Silverthorne
- 18 Dec 2007
- First Look
First Look: December 18, 2007
affects emotions. Finally, work in economics on the design of monetary policy makes several assumptions (e.g., a representative agent, a summary measure of emotions akin to utility exists and that individuals only care about income and... View Details
Keywords: Martha Lagace
- 05 Jun 2013
- What Do You Think?
Do We Need to Extend ‘No Surprises Management?’
commented, ''No Surprises Management seems pretty obvious. Why in the world would you want the people you're counting on to help you achieve your objectives to be blindsided?" Roger Studer added, "Take care of those who take... View Details
Keywords: by James Heskett
- November 1998 (Revised June 1999)
- Case
MedSim
An Israeli high-tech start-up has developed an innovative simulator which makes possible non-patient training in medical ultrasound. The marketing function moves to the United States, the largest market, while other functions remain in Israel. The case describes a... View Details
- 10 Mar 2002
- Research & Ideas
Breakthrough Negotiation: Don’t Leave It On the Table
bolster their bargaining power, and channeling the flow of the process through time. They understand that actions taken away from the negotiating table can be as important as what goes on at the table, if not more so.1 Specifically, skilled negotiators recognize that... View Details
Keywords: by Michael Watkins
- July 2000 (Revised September 2005)
- Case
Guidant: Radiation Therapy
Describes a potential new approach to treating cardiac disease--radiation therapy. Guidant, a leading medical device maker, faces a choice about whether to pursue this new and risky technology and, if so with what strategy. View Details
Keywords: Entrepreneurship; Decisions; Innovation Strategy; Health Care and Treatment; Product Design; Corporate Strategy; Medical Specialties; Health Industry; Health Industry
Roberts, Michael J., and Diana S. Gardner. "Guidant: Radiation Therapy." Harvard Business School Case 801-040, July 2000. (Revised September 2005.)
- 08 Jun 2010
- First Look
First Look: June 8
model for inflammatory bowel disease in 2001 and 2009, before and after the reorganization. The case can be used to examine health care provider strategy, integrated care... View Details
Keywords: Martha Lagace
- 18 Sep 2007
- First Look
First Look: September 18, 2007
"dashboard," and the Performance Manager. Provides students with an opportunity to identify key design principles for health care information systems, and to discuss the unique implementation... View Details
Keywords: Martha Lagace
- 2024
- Working Paper
Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances
By: Amar Bhidé and Srikant M. Datar
In 2017, the US Food and Drug Administration (FDA) approved an immunotherapeutic treatment, called CAR-T therapy, for two kinds of blood cancers—acute leukemia (ALL) and a lymphoma. We describe 1) how CAR-T works, 2) the foundational advances and discoveries, 3) the... View Details
Keywords: Immunotherapy; Health Care and Treatment; Innovation and Invention; Research and Development; Governing Rules, Regulations, and Reforms
Bhidé, Amar, and Srikant M. Datar. "Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 21-035, August 2020. (Revised May 2024.)
- January 2018
- Case
Spark Therapeutics: Pioneering Gene Therapy
By: Robert F. Higgins and Tina Liu
Spark Therapeutics is a pioneering gene therapy startup. It was spun out of The Children’s Hospital of Philadelphia (CHOP). The company had taken with it much of the intellectual property and talent that CHOP had developed. The company is considering an initial public... View Details
Keywords: Health Care and Treatment; Innovation and Invention; Business Startups; Opportunities; Problems and Challenges; Strategy
Higgins, Robert F., and Tina Liu. "Spark Therapeutics: Pioneering Gene Therapy." Harvard Business School Case 818-059, January 2018.
- April 2017
- Supplement
Imprimis (C)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A & B). Set in 2015, it first describes Imprimis’s decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the... View Details
Keywords: Health Care and Treatment; Cost; Moral Sensibility; Competitive Strategy; Decision Choices and Conditions; Pharmaceutical Industry; United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (C)." Harvard Business School Supplement 717-497, April 2017.
- 03 Jun 2008
- First Look
First Look: June 3, 2008
Implementing Patient-Focused Care (A) (Abridged) Harvard Business School Case 608-070 Reading Rehab Hospital has experimented with a popular concept in health care—patient-focused care—intended to increase... View Details
Keywords: Martha Lagace
- 13 May 2014
- First Look
First Look: May 13
Harvard Business School Case 714-471 Martini Klinik: Prostate Cancer Care Since its establishment in 2005, Hamburg's Martini Klinik had single mindedly focused on prostate cancer care with a commitment to... View Details
Keywords: Sean Silverthorne
- 17 Mar 2009
- First Look
First Look: March 17, 2009
Bowes adapted its approach to employee health amid rising health care costs, shifting employer attitudes towards health benefits and a rapidly... View Details
Keywords: Martha Lagace
- February 2016
- Case
Express Scripts: Promoting Prescription Drug Home Delivery (A)
By: John Beshears, Patrick Rooney and Jenny Sanford
The pharmacy benefit manager (PBM) sector processes prescription drug claims on behalf of companies that offer a prescription drug benefit to their employees. This case follows Bob Nease, Chief Scientist at Express Scripts, as he considers methods to promote home... View Details
Keywords: Pharmaceuticals; Prescription Drugs; Pharmacy Benefit Manager; PBM; Healthcare; Behavioral Economics; Choice Architecture; Active Choice; Service Delivery; Decision Choices and Conditions; Health Care and Treatment; Order Taking and Fulfillment; Compensation and Benefits; Pharmaceutical Industry
Beshears, John, Patrick Rooney, and Jenny Sanford. "Express Scripts: Promoting Prescription Drug Home Delivery (A)." Harvard Business School Case 916-026, February 2016.
- 05 Feb 2009
- What Do You Think?
Why Can’t We Figure Out How to Select Leaders?
excellence does (not always) breed excellence because some of the best leaders may still not be the best selectors." Dick Meza suggested that "The issue here may be the degree to which senior management cares about... View Details
Keywords: by Jim Heskett
- 05 Aug 2014
- First Look
First Look: August 5
important and previously unidentified metric for assessing the health of the human emotional ecosystem. Publisher's link: http://www.hbs.edu/faculty/Publication%20Files/quoidbach%20et%20al_372259e1-d8a0-4488-b09a-b4978f06f406.pdf August... View Details
Keywords: Sean Silverthorne
- June 2004 (Revised May 2005)
- Case
Judah Folkman and the War on Cancer
Judah Folkman, professor in the Division of Vascular Biology at Children's Hospital in Boston, is considering how best to advance the research in his lab in an era where biomedical research has gotten more interdisciplinary and collaborative. Specifically, Folkman has... View Details
Keywords: Conflict of Interests; Leadership; Research; Personal Development and Career; Health Care and Treatment; Collaborative Innovation and Invention; Health Industry; Health Industry; Boston
West, Jonathan, Ambuj Sagar, and Mona Ashiya. "Judah Folkman and the War on Cancer." Harvard Business School Case 604-091, June 2004. (Revised May 2005.)
- 14 Feb 2012
- First Look
First Look: February 14
individuals bring well-articulated preexisting preferences to such decisions. Understanding beliefs and attitudes motivating these preferences can assist physicians in helping parents make informed decisions consistent with their values. Consumer-Driven View Details
Keywords: Carmen Nobel
- 08 Jul 2015
- What Do You Think?
Do Americans Work Too Much and Think About Work Too Little?
an additional 5 million people full-time, non-executive employees making up to about $50,000 per year. Any number of outcomes are predicted: More jobs. Fewer jobs. More productivity. Less productivity. Lower profits. No significant effect... View Details